Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study

Publication date: Available online 6 April 2021Source: The Lancet Respiratory MedicineAuthor(s): Timothy A Yap, Kazuhiko Nakagawa, Nobukazu Fujimoto, Kozo Kuribayashi, Tormod Kyrre Guren, Luana Calabrò, Ronnie Shapira-Frommer, Bo Gao, Steven Kao, Ignacio Matos, David Planchard, Arkendu Chatterjee, Fan Jin, Kevin Norwood, Hedy L Kindler
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research